Cellcentric Is A Biotechnology Company Founded In 2004 By Profazim Suranian Expert In Cell Fate Control Researchthe Company Is Dedicated To Developing Innovative Treatments For Specific Cancersparticularly Multiple Myelomaby Targeting The P300 Cbp Protein Involved In Cancer Progression The Company S Mission Is To Improve Outcomes For Patients With Specific Cancers By Quickly Advancing Effective Treatmentscellcentric Focuses On Identifying Novel Targets And Mechanisms In Cancer Treatmentcollaborating With Leading Research Centersand Engaging With Patients To Understand Their Needsits Primary Product In Development Is Inobrodiban Oral Drug That Inhibits P300 Cbp And Is Currently Undergoing Clinical Trialsthrough Its Research And Development Effortscellcentric Aims To Make A Significant Impact In The Field Of Cancer Treatment
